Allogeneic Cultured Islet Cells (human); Encapsulated

Developed for: type 1 diabetes mellitus
Investigated by: CHRISTUS Health · Diabetes & Glandular Disease Research Associates, P.A., San Antonio, TX · Novocell

today NCT00260234 · Ph 1/2

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT00260234	Nov 2005 → Dec 2007	type 1 diabetes mellitus	Novocell	Terminated	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Allogeneic Cultured Islet Cells (human); Encapsulated	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00260234 ↗
Route	Subcutaneous	“Administered Subcutaneously” NCT00260234 ↗